Impact of Changes in Early Respiratory Support Management on Respiratory Outcomes of Preterm Infants
- PMID: 35764345
- DOI: 10.4187/respcare.09963
Impact of Changes in Early Respiratory Support Management on Respiratory Outcomes of Preterm Infants
Abstract
Background: In the period immediately after birth, preterm infants are highly susceptible to lung injury. Ventilator-induced lung injury has been recognized as a major contributing factor for bronchopulmonary dysplasia (BPD) in preterm infants. Noninvasive respiratory support (NIRS) could decrease lung injury, and early respiratory support management might affect pulmonary outcomes. We conducted a study to evaluate the changes in early respiratory support management and their impact on respiratory outcome and complications of preterm infants in 3 different time periods over the last 13 years.
Methods: This study was a retrospective, single-center cohort study. We retrospectively reviewed the medical records of preterm infants < 32 weeks of gestational age born in our hospital from 2007-2020. The study period was divided into three 3-y discrete periods: 2007-2009 (period A), 2013-2015 (period B), and 2018-2020 (period C). Changes in early respiratory support management were assessed in the 3 periods. The outcomes measured included mortality, BPD, other major neonatal complications, initial respiratory support, and duration of mechanical ventilation.
Results: In all, 1,880 clinical records were assessed in our study, with 358 in period A, 825 in period B, and 697 in period C. The use of antenatal corticosteroids increased over time (56.1% in period A, 56.7% in period B, and 74.0% in period C (P < .001). The need for surfactant decreased from 65.6% in period A to 40.7% in period B and 45.9% in period C. Increased utilization of NIRS was associated with decreased invasive mechanical ventilation within 24 h after birth. NIRS only during the hospital stay increased from 22.9% in period A to 36.8% and 45.1% in the latter 2 periods (P < .001). Oxygen therapy duration decreased from 24.3 d in period A to 14.4 d in period B and 17.2 d in period C (P < .001). The overall incidence of BPD was 32.4% in the first period, 23.9% in the second period, and 25.4% in the third period (P < .001). The moderate-to-severe forms of BPD decreased from 12.8% in period A to 7.9% in period B and 7.6% in period C (P = .009). Other neonatal complications, such as pneumothorax, pulmonary hemorrhage, persistent pulmonary hypertension of the newborn, surgical necrotizing enterocolitis, intraventricular hemorrhage grade III/IV, and periventricular leukomalacia, were unchanged among the 3 periods.
Conclusions: From 2007-2020, respiratory management was characterized by a marked reduction in invasive mechanical ventilation and an increase in the use of NIRS. Changes in early respiratory support management resulted in improved respiratory outcomes with a decrease in the overall incidence of BPD. It is likely that our aim to reduce lung injury by improving our respiratory management has contributed to a favorable outcome.
Keywords: bronchopulmonary dysplasia; complications; early respiratory support management; preterm infants; respiratory outcome.
Copyright © 2022 by Daedalus Enterprises.
Conflict of interest statement
The authors have disclosed no conflicts of interest.
Similar articles
-
Impact of implementation of 2019 European respiratory distress syndrome guidelines on bronchopulmonary dysplasia in very preterm infants.Ital J Pediatr. 2024 Sep 16;50(1):178. doi: 10.1186/s13052-024-01752-4. Ital J Pediatr. 2024. PMID: 39285390 Free PMC article.
-
Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China.BMC Pulm Med. 2022 Dec 5;22(1):462. doi: 10.1186/s12890-022-02270-x. BMC Pulm Med. 2022. PMID: 36471386 Free PMC article.
-
Multicenter controlled clinical trial of high-frequency jet ventilation in preterm infants with uncomplicated respiratory distress syndrome.Pediatrics. 1997 Oct;100(4):593-9. doi: 10.1542/peds.100.4.593. Pediatrics. 1997. PMID: 9310511 Clinical Trial.
-
Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.Neonatology. 2015;107(4):358-9. doi: 10.1159/000381132. Epub 2015 Jun 5. Neonatology. 2015. PMID: 26044104 Review.
-
Invasive and non-invasive ventilatory strategies for early and evolving bronchopulmonary dysplasia.Semin Perinatol. 2023 Oct;47(6):151815. doi: 10.1016/j.semperi.2023.151815. Epub 2023 Sep 9. Semin Perinatol. 2023. PMID: 37775369 Review.
Cited by
-
Somatic growth outcomes in response to an individualized neonatal sodium supplementation protocol.Res Sq [Preprint]. 2024 Feb 5:rs.3.rs-3911085. doi: 10.21203/rs.3.rs-3911085/v1. Res Sq. 2024. Update in: J Perinatol. 2025 Mar;45(3):305-311. doi: 10.1038/s41372-024-02141-9. PMID: 38405851 Free PMC article. Updated. Preprint.
-
Large airway T cells in adults with former bronchopulmonary dysplasia.Respir Res. 2024 Feb 9;25(1):86. doi: 10.1186/s12931-024-02717-1. Respir Res. 2024. PMID: 38336805 Free PMC article.
-
Somatic growth outcomes in response to an individualized neonatal sodium supplementation protocol.J Perinatol. 2025 Mar;45(3):305-311. doi: 10.1038/s41372-024-02141-9. Epub 2024 Oct 17. J Perinatol. 2025. PMID: 39420073 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources